PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	56.56	73.82	65.24	28.84
Cash & Short-Term Investments	49.75	56.56	73.82	65.24	28.84
Cash Growth	-12.04%	-23.38%	13.15%	126.23%	137.13%
Prepaid Expenses	-	2.49	2.66	1.6	1.5
Total Current Assets	-	59.06	76.48	66.84	30.34
Property, Plant & Equipment	-	0.34	0.53	0.36	0.55
Total Assets	-	59.39	77.01	67.2	30.89
Accounts Payable	-	6.98	1.22	1.31	1.42
Accrued Expenses	-	2.42	8.31	2.19	1.74
Short-Term Debt	-	4.17	-	-	-
Current Portion of Leases	-	0.06	0.29	0.26	0.12
Total Current Liabilities	-	13.63	9.82	3.76	3.27
Long-Term Debt	-	19.51	23.02	-	-
Long-Term Leases	-	0.12	0.16	0.23	0.49
Total Liabilities	-	33.26	33.01	3.99	3.76
Common Stock	-	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	170.62	145.55	123.9	70.91
Retained Earnings	-	-144.5	-101.56	-60.7	-43.79
Shareholders' Equity	22	26.13	44	63.21	27.13
Total Liabilities & Equity	-	59.39	77.01	67.2	30.89
Total Debt	24.67	23.85	23.47	0.49	0.61
Net Cash (Debt)	25.08	32.71	50.35	64.75	28.23
Net Cash Growth	-23.32%	-35.03%	-22.25%	129.38%	132.12%
Net Cash Per Share	0.69	1.06	1.76	2.53	1.69
Filing Date Shares Outstanding	37.41	36.68	30.72	28.45	22.26
Total Common Shares Outstanding	36.82	33.09	30.17	28.45	22.26
Working Capital	-	45.43	66.66	63.08	27.07
Book Value Per Share	0.60	0.79	1.46	2.22	1.22
Tangible Book Value	22	26.13	44	63.21	27.13
Tangible Book Value Per Share	0.60	0.79	1.46	2.22	1.22
Machinery	-	0.27	0.12	0.12	0.12

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q